To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension

NCT02047656 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Part 1 - Healthy Volunteers
Part 2 - Patients With Hypertension

Interventions

DRUG: LFF269
DRUG: Placebo to LFF269

Sponsor

Novartis Pharmaceuticals